July 30, 2021
Misonix, Inc. Investigation
WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Misonix, Inc. (“Misonix” or the “Company”) (NASDAQ: MSON) in connection with the proposed cash-and-stock acquisition of the Company by Bioventus Inc. (“Bioventus”) (NASDAQ: BVS). Under the terms of the merger agreement, Misonix shareholders may elect to receive either (i) 1.6839 shares of Bioventus stock, representing implied per-share merger consideration of approximately $29.05 based upon Bioventus’s July 29, 2021 closing price of $17.25, or (ii) $28.00 in cash, without interest, for each share of Misonix common stock.
Join Case →